IDCS Amyloid beta Series – Professor Sir John Hardy

The International Dementia Conference Series (IDCS) has rapidly evolved into a mentorship program focused on nurturing the next generation of dementia scientists. Our core values are excellence, diversity, and innovation. The program is an ever-evolving project where everyone, from undergraduate to emeritus, is invited to participate and contribute.  

Experienced investigators are invited to elaborate on the most pressing problems in neurodegeneration and devise solutions thereby encouraging collaboration among student groups. The generosity of the scientists in our community also enables one-on-one mentorship. 

IDCS has a new webinar series starting with Professor Sir John Hardy on 23rd August. The topic this time is the famous, or infamous, “Amyloid-β”.

Prof John Hardy is a world-leading neurogeneticist in the field of neurodegenerative diseases, receiving numerous accolades that include the Breakthrough Prize in Life Sciences, the Brain Prize and, in 2009, being elected a Fellow of the Royal Society. In 1991, Hardy’s team uncovered the first mutation directly implicated in Alzheimer’s disease leading to the formulation of the highly influential ‘amyloid-cascade’ hypothesis. His extensive body of work in genetics will be built upon in this UK DRI programme, where the team will unravel pathogenic networks in neurodegenerative disease.

Zoom Link For All Lectures – https://mcgill.zoom.us/j/3505997027 – Meeting ID: 350 599 7027

Upcoming Series Events